Update – Early 2014 hope for EMA public hearings
This article was originally published in Scrip
Executive Summary
Public hearings on marketed medicines could take place from the beginning of next year in Europe, the European Medicines Agency has clarified to Scrip. The agency hopes the hearings will both improve transparency and better include patient views about acceptable risk levels.